Table 4 Paraoxonase activity and biochemical parameters in metastatic and non-metastatic lung cancer patients
From: Serum paraoxonase and arylesterase activities in patients with lung cancer in a Turkish population
| Â | Nonmetastatic LC patients (n=19) | Metastatic LC patients (n=20) | P value |
|---|---|---|---|
Total cholesterol (mg/dl) | 169.7 ± 57.6 | 160.7 ± 42.7 | 0.66 |
LDL cholesterol (mg/dl) | 115.3 ± 45.8 | 116.6 ± 40.1 | 0.94 |
HDL cholesterol (mg/dl) | 38.8 ± 28.5 | 31.1 ± 8.1 | 0.62 |
Triglyceride (mg/dl) | 149.9 ± 55.7 | 133.2 ± 52.4 | 0.41 |
PON1 (U/mL) | 245.6 ± 115.7 | 259.5 ± 94.9 | 0.70 |
ARE (U/L) | 120 ± 47 | 153.9 ± 62.9 | 0.09 |